Form 8-K - Current report:
SEC Accession No. 0001339970-26-000039
Filing Date
2026-06-08
Accepted
2026-06-08 16:04:31
Documents
9
Period of Report
2026-06-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K atyr-20260603.htm   iXBRL 8-K 56347
  Complete submission text file 0001339970-26-000039.txt   164007

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atyr-20260603.xsd EX-101.SCH 26019
12 EXTRACTED XBRL INSTANCE DOCUMENT atyr-20260603_htm.xml XML 4710
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 261072556
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)